TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia - PubMed (original) (raw)
TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia
Jan Zuna et al. Clin Cancer Res. 2004.
Abstract
Purpose: TEL (ETV6)-AML1 (RUNX1) chimeric gene fusions are frequent genetic abnormalities in childhood acute lymphoblastic leukemia (ALL). They often arise prenatally as early events or initiating events and are complemented by secondary postnatal genetic events of which deletion of the non-rearranged, second TEL allele is the most common. This consistent sequence of molecular pathogenesis facilitates an analysis of the clonal origins of relapse in this leukemia, which has some unusual clinical features.
Experimental design: We compared the boundaries, by microsatellite mapping, of TEL deletions at relapse versus diagnosis in 15 informative patients. Moreover, we compared the relatedness of diagnostic and relapse clones using immunoglobulin and T-cell receptor genes rearrangements and clonotypic TEL-AML1 genomic fusion.
Results: Five patients retained the apparent same size TEL deletion, seven had larger deletions, and three had smaller deletions at relapse. In all of the cases evaluated, the clonal relatedness of diagnostic and relapse cells was confirmed by the retention of clonotypic TEL-AML1 genomic sequence and/or at least one identical immunoreceptor gene rearrangement.
Conclusions: These data provide further evidence that TEL deletions are secondary to TEL-AML1 fusions in ALL. They are compatible with the novel idea that in at least some cases of childhood ALL, remission occurs with persistence of a preleukemic "fetal" clone, and subsequent relapse reflects the emergence of a new subclone from this reservoir after an independent "second hit," i.e., independent TEL deletion. To our knowledge, the study is the most extensive and comprehensive analysis of the relationship between diagnostic and relapse clones in childhood ALL presented thus far.
Similar articles
- ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
Martineau M, Jalali GR, Barber KE, Broadfield ZJ, Cheung KL, Lilleyman J, Moorman AV, Richards S, Robinson HM, Ross F, Harrison CJ. Martineau M, et al. Genes Chromosomes Cancer. 2005 May;43(1):54-71. doi: 10.1002/gcc.20158. Genes Chromosomes Cancer. 2005. PMID: 15704129 - Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R. Stams WA, et al. Clin Cancer Res. 2005 Apr 15;11(8):2974-80. doi: 10.1158/1078-0432.CCR-04-1829. Clin Cancer Res. 2005. PMID: 15837750 - Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
Martínez-Ramírez A, Urioste M, Contra T, Cantalejo A, Tavares A, Portero JA, López-Ibor B, Bernacer M, Soto C, Cigudosa JC, Benítez J. Martínez-Ramírez A, et al. Haematologica. 2001 Dec;86(12):1245-53. Haematologica. 2001. PMID: 11726315 - [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
Zuna J. Zuna J. Cas Lek Cesk. 2001 Mar 15;140(5):131-7. Cas Lek Cesk. 2001. PMID: 11347199 Review. Czech. - Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.
Zelent A, Greaves M, Enver T. Zelent A, et al. Oncogene. 2004 May 24;23(24):4275-83. doi: 10.1038/sj.onc.1207672. Oncogene. 2004. PMID: 15156184 Review.
Cited by
- The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
Dander E, Palmi C, D'Amico G, Cazzaniga G. Dander E, et al. Int J Mol Sci. 2021 Apr 23;22(9):4426. doi: 10.3390/ijms22094426. Int J Mol Sci. 2021. PMID: 33922612 Free PMC article. Review. - ETV6-related thrombocytopenia and leukemia predisposition.
Di Paola J, Porter CC. Di Paola J, et al. Blood. 2019 Aug 22;134(8):663-667. doi: 10.1182/blood.2019852418. Epub 2019 Jun 27. Blood. 2019. PMID: 31248877 Free PMC article. - Translocations involving ETS family proteins in human cancer.
Fry EA, Mallakin A, Inoue K. Fry EA, et al. Integr Cancer Sci Ther. 2018 Aug;5(4):10.15761/ICST.1000281. doi: 10.15761/ICST.1000281. Epub 2018 Jul 20. Integr Cancer Sci Ther. 2018. PMID: 30542624 Free PMC article. - Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
Sun C, Chang L, Zhu X. Sun C, et al. Oncotarget. 2017 May 23;8(21):35445-35459. doi: 10.18632/oncotarget.16367. Oncotarget. 2017. PMID: 28418909 Free PMC article. Review. - Childhood Leukemia and Primary Prevention.
Whitehead TP, Metayer C, Wiemels JL, Singer AW, Miller MD. Whitehead TP, et al. Curr Probl Pediatr Adolesc Health Care. 2016 Oct;46(10):317-352. doi: 10.1016/j.cppeds.2016.08.004. Curr Probl Pediatr Adolesc Health Care. 2016. PMID: 27968954 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources